HOTH news

Hoth Therapeutics filed a Certificate of Amendment to its Articles of Incorporation on May 20, 2026, with an effective date of May 26, 2026. The filing indicates changes to the entity's registered agent and potentially other corporate governance matters.

Hoth Therapeutics entered into an exclusive license agreement with Virginia Commonwealth University to commercialize patent-protected technology. The licensing arrangement provides Hoth access to VCU-developed intellectual property for product development in its field of use.